Novel biomarkers for glycaemic deterioration in type 2 diabetes: an IMI RHAPSODY study
Roderick C Slieker, Louise A Donnelly, Livia Lopez-Noriega, Hermine Muniangi-Muhitu, Elina Akalestou, Mahsa Sheikh, Eleni Georgiadou, Giuseppe N. Giordano, Mikael Åkerlund, Emma Ahlqvist, Ashfaq Ali, Marko Barovic, Gerard A Bouland, Frédéric Burdet, Mickaël Canouil, Iulian Dragan, Petra JM Elders, Celine Fernandez, Andreas Festa, Hugo Fitipaldi, Phillippe Froguel, Valborg Gudmundsdottir, Vilmundur Gudnason, Mathias J. Gerl, Amber A van der Heijden, Lori L Jennings, Michael K. Hansen, Min Kim, Isabelle Leclerc, Christian Klose, Dmitry Kuznetsov, Dina Mansour Aly, Florence Mehl, Diana Marek, Olle Melander, Anne Niknejad, Filip Ottosson, Imre Pavo, Alexander Efanov, Kevin Duffin, Timothy J. Pullen, Kai Simons, Michele Solimena, Tommi Suvitaival, Asger Wretlind, Peter Rossing, Valeriya Lyssenko, Cristina Legido Quigley, Leif Groop, Bernard Thorens, Paul W Franks, Mark Ibberson, Joline WJ Beulens, Leen M ’t Hart, Ewan R Pearson, Guy A Rutter
doi: https://doi.org/10.1101/2021.04.22.21255625
Roderick C Slieker
1Department of Epidemiology and Data Science, Amsterdam Public Health Institute, Amsterdam Cardiovascular Sciences, Amsterdam UMC, location VUMC, Amsterdam, the Netherlands
2Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands
PhDLouise A Donnelly
3Population Health & Genomics, School of Medicine, University of Dundee, Dundee, UK
PhDLivia Lopez-Noriega
4Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.
PhDHermine Muniangi-Muhitu
4Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.
Elina Akalestou
4Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.
PhDMahsa Sheikh
4Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.
Eleni Georgiadou
4Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.
PhDGiuseppe N. Giordano
5Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
PhDMikael Åkerlund
5Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
PhDEmma Ahlqvist
5Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
PhDAshfaq Ali
6Steno Diabetes Center Copenhagen, Gentofte, Denmark
PhDMarko Barovic
7Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany
MScGerard A Bouland
2Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands
MScFrédéric Burdet
8Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
MScMickaël Canouil
9INSERM U1283, CNRS UMR 8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, University of Lille, Lille University Hospital, Lille, F-59000, France
PhDIulian Dragan
8Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
MScPetra JM Elders
10Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, Amsterdam UMC–location VUmc, Amsterdam, the Netherlands
PhDCeline Fernandez
5Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
PhDAndreas Festa
11Eli Lilly Regional Operations GmbH, Vienna, Austria
121st Medical Department, LK Stockerau, Niederösterreich, Austria.
MDHugo Fitipaldi
5Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
MScPhillippe Froguel
9INSERM U1283, CNRS UMR 8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, University of Lille, Lille University Hospital, Lille, F-59000, France
13Division of Systems Biology, Department of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK
Valborg Gudmundsdottir
14Faculty of Medicine, University of Iceland, Reykjavik, Iceland
15Icelandic Heart Association, Kopavogur, Iceland
PhDVilmundur Gudnason
14Faculty of Medicine, University of Iceland, Reykjavik, Iceland
15Icelandic Heart Association, Kopavogur, Iceland
MD, PhDMathias J. Gerl
16Lipotype GmbH Dresden Germany
PhDAmber A van der Heijden
10Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, Amsterdam UMC–location VUmc, Amsterdam, the Netherlands
PhDLori L Jennings
17Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
PhDMichael K. Hansen
18Cardiovascular and Metabolic Disease Research, Janssen Research & Development, Spring House, Pennsylvania, U.S.A.
PhDMin Kim
6Steno Diabetes Center Copenhagen, Gentofte, Denmark
19Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicines, King’s College London, London, United Kingdom
PhDIsabelle Leclerc
4Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.
MD PhDChristian Klose
16Lipotype GmbH Dresden Germany
PhDDmitry Kuznetsov
8Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
PhDDina Mansour Aly
5Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
MScFlorence Mehl
8Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
PhDDiana Marek
8Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
PhDOlle Melander
5Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
PhDAnne Niknejad
8Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
MScFilip Ottosson
5Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
MScImre Pavo
11Eli Lilly Regional Operations GmbH, Vienna, Austria
MDAlexander Efanov
20Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, United States
PhDKevin Duffin
20Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, United States
Timothy J. Pullen
4Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.
21Department of Diabetes, Guy’s Campus King’s College London, U.K.
PhDKai Simons
16Lipotype GmbH Dresden Germany
PhDMichele Solimena
7Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany
22Molecular Diabetology, University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany
PhDTommi Suvitaival
6Steno Diabetes Center Copenhagen, Gentofte, Denmark
PhDAsger Wretlind
6Steno Diabetes Center Copenhagen, Gentofte, Denmark
MScPeter Rossing
6Steno Diabetes Center Copenhagen, Gentofte, Denmark
23Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
MDValeriya Lyssenko
24Department of Clinical Science, Center for Diabetes Research, University of Bergen, Bergen, Norway
25Genomics, Diabetes and Endocrinology Unit, Department of Clinical Sciences Malmö, Lund University Diabetes Centre, Skåne University Hospital, Malmö, Sweden
PhDCristina Legido Quigley
6Steno Diabetes Center Copenhagen, Gentofte, Denmark
19Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicines, King’s College London, London, United Kingdom
PhDLeif Groop
5Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
26Finnish Institute of Molecular Medicine, Helsinki University, Helsinki, Finland
PhDBernard Thorens
27Center for Integrative Genomics, University of Lausanne, CH-1015, Lausanne, Switzerland
PhDPaul W Franks
5Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
28Department of Nutrition, Harvard School of Public Health, Boston, MA, USA
PhDMark Ibberson
7Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany
PhDJoline WJ Beulens
1Department of Epidemiology and Data Science, Amsterdam Public Health Institute, Amsterdam Cardiovascular Sciences, Amsterdam UMC, location VUMC, Amsterdam, the Netherlands
29Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
PhDLeen M ’t Hart
1Department of Epidemiology and Data Science, Amsterdam Public Health Institute, Amsterdam Cardiovascular Sciences, Amsterdam UMC, location VUMC, Amsterdam, the Netherlands
2Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands
30Department of Biomedical Data Sciences, Section Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
PhDEwan R Pearson
3Population Health & Genomics, School of Medicine, University of Dundee, Dundee, UK
MDGuy A Rutter
4Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.
31Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
PhD
- Supp. Fig. 1[supplements/255625_file03.pdf]
- Supp Tables S1-S3[supplements/255625_file04.docx]
- Table S4[supplements/255625_file05.xlsx]
- Table S5[supplements/255625_file06.xlsx]
- Table S6[supplements/255625_file07.xlsx]
Posted April 24, 2021.
Novel biomarkers for glycaemic deterioration in type 2 diabetes: an IMI RHAPSODY study
Roderick C Slieker, Louise A Donnelly, Livia Lopez-Noriega, Hermine Muniangi-Muhitu, Elina Akalestou, Mahsa Sheikh, Eleni Georgiadou, Giuseppe N. Giordano, Mikael Åkerlund, Emma Ahlqvist, Ashfaq Ali, Marko Barovic, Gerard A Bouland, Frédéric Burdet, Mickaël Canouil, Iulian Dragan, Petra JM Elders, Celine Fernandez, Andreas Festa, Hugo Fitipaldi, Phillippe Froguel, Valborg Gudmundsdottir, Vilmundur Gudnason, Mathias J. Gerl, Amber A van der Heijden, Lori L Jennings, Michael K. Hansen, Min Kim, Isabelle Leclerc, Christian Klose, Dmitry Kuznetsov, Dina Mansour Aly, Florence Mehl, Diana Marek, Olle Melander, Anne Niknejad, Filip Ottosson, Imre Pavo, Alexander Efanov, Kevin Duffin, Timothy J. Pullen, Kai Simons, Michele Solimena, Tommi Suvitaival, Asger Wretlind, Peter Rossing, Valeriya Lyssenko, Cristina Legido Quigley, Leif Groop, Bernard Thorens, Paul W Franks, Mark Ibberson, Joline WJ Beulens, Leen M ’t Hart, Ewan R Pearson, Guy A Rutter
medRxiv 2021.04.22.21255625; doi: https://doi.org/10.1101/2021.04.22.21255625
Novel biomarkers for glycaemic deterioration in type 2 diabetes: an IMI RHAPSODY study
Roderick C Slieker, Louise A Donnelly, Livia Lopez-Noriega, Hermine Muniangi-Muhitu, Elina Akalestou, Mahsa Sheikh, Eleni Georgiadou, Giuseppe N. Giordano, Mikael Åkerlund, Emma Ahlqvist, Ashfaq Ali, Marko Barovic, Gerard A Bouland, Frédéric Burdet, Mickaël Canouil, Iulian Dragan, Petra JM Elders, Celine Fernandez, Andreas Festa, Hugo Fitipaldi, Phillippe Froguel, Valborg Gudmundsdottir, Vilmundur Gudnason, Mathias J. Gerl, Amber A van der Heijden, Lori L Jennings, Michael K. Hansen, Min Kim, Isabelle Leclerc, Christian Klose, Dmitry Kuznetsov, Dina Mansour Aly, Florence Mehl, Diana Marek, Olle Melander, Anne Niknejad, Filip Ottosson, Imre Pavo, Alexander Efanov, Kevin Duffin, Timothy J. Pullen, Kai Simons, Michele Solimena, Tommi Suvitaival, Asger Wretlind, Peter Rossing, Valeriya Lyssenko, Cristina Legido Quigley, Leif Groop, Bernard Thorens, Paul W Franks, Mark Ibberson, Joline WJ Beulens, Leen M ’t Hart, Ewan R Pearson, Guy A Rutter
medRxiv 2021.04.22.21255625; doi: https://doi.org/10.1101/2021.04.22.21255625
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)